Internal Medicine, Medical Oncology · St Joseph, MO
NPI
1548226541
Since 2006
Specialty
Internal Medicine, Medical Oncology
Code 207RX0202X
Group practices
3
Medicare group memberships
Hospitals
5
Hospital affiliations
902 No Riverside Rd, Suite 200
St Joseph, MO, 64507
Phone (816) 271-1301
Groups this clinician bills Medicare through
Medicare paid, 2024
$317K
6,057 services
Medicare patients, 2024
1,053
Average age 75
Drug cost, 2024
$10.3M
4,247 prescriptions
Company payments, 2025
$664
From 9 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Rony M Abou-Jawde was code 99214 (office e&m - established), 2,770 times for 864 patients. In total Rony M Abou-Jawde billed 6,057 services in 38 codes, and Medicare paid $317K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2017-08-22.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 2,770 | 864 | $67.11 | $186K |
| 99232 Hospital E&M - Subsequent | Facility | 414 | 135 | $58.85 | $24K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 378 | 276 | $12.39 | $4,683 |
| 99215 Office E&M - Established | Facility | 370 | 197 | $101.77 | $38K |
| 99233 Hospital E&M - Subsequent | Facility | 275 | 124 | $87.83 | $24K |
| 99213 Office E&M - Established | Facility | 102 | 87 | $43.32 | $4,418 |
| 99222 Hospital E&M - Initial | Facility | 82 | 75 | $96.50 | $7,913 |
| 99204 Office E&M - New | Facility | 78 | 78 | $92.06 | $7,181 |
| 99205 Office E&M - New | Facility | 53 | 53 | $128.21 | $6,795 |
By year: 2022 $324K for 7,953 services; 2023 $320K for 7,960 services; 2024 $317K for 6,057 services.
Medicare prescription drug claims, 2024
In 2024, the drug Rony M Abou-Jawde prescribed most often to Medicare patients was Anastrozole, with 698 prescriptions and refills. In total Rony M Abou-Jawde wrote 4,247 Medicare prescriptions that cost $10.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Anastrozole Generic | 698 | 1,314 | 144 | $8,596 |
| Prednisone Generic | 389 | 454 | 111 | $2,179 |
| Ondansetron Hcl Generic | 198 | 198 | 136 | $1,899 |
| Abiraterone Acetate Generic | 185 | 194 | 22 | $307K |
| Prochlorperazine Maleate Generic | 174 | 174 | 125 | $1,569 |
| Gabapentin Generic | 164 | 241 | 36 | $2,217 |
| Acyclovir Generic | 133 | 187 | 24 | $1,592 |
| Potassium Chloride Generic | 123 | 168 | 31 | $2,004 |
| Lenalidomide Generic | 106 | 106 | 13 | $1.5M |
| Xtandi Enzalutamide | 106 | 106 | 12 | $1.3M |
| Letrozole Generic | 103 | 171 | 22 | $1,355 |
| Duloxetine Hcl Generic | 94 | 142 | 18 | $1,008 |
| Warfarin Sodium Generic | 87 | 130 | Under 11 | $660 |
| Hydroxyurea Generic | 86 | 169 | 19 | $2,075 |
| Dexamethasone Generic | 85 | 102 | 36 | $1,385 |
Brand drugs: 589 claims; generic drugs: 3,658 claims; opioid claims: 130.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Rony M Abou-Jawde $664 ($664 in general payments such as food, travel and fees) from 9 companies. The largest payer was Daiichi Sankyo Inc. with $144.
| Company | Payments | Amount |
|---|---|---|
| Daiichi Sankyo Inc. 4568.T | 3 | $144 |
| Abbvie Inc. ABBV | 5 | $119 |
| Merit Medical Systems Inc MMSI | 1 | $115 |
| Pfizer Inc. PFE | 4 | $86.07 |
| E.R. Squibb & Sons, L.L.C. BMY | 5 | $79.55 |
| Recordati_rare_diseases_inc. | 2 | $45.26 |
| Novartis Pharmaceuticals Corporation NVS | 2 | $31.35 |
| AstraZeneca Pharmaceuticals LP AZN | 1 | $24.04 |
| Merck Sharp & Dohme LLC MRK | 1 | $19.52 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.